Metilfenobarbital [Inn-Spanish] en es it fr

Metilfenobarbital [Inn-Spanish] Brand names, Metilfenobarbital [Inn-Spanish] Analogs

Metilfenobarbital [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Metilfenobarbital [Inn-Spanish] Chemical_Formula


Metilfenobarbital [Inn-Spanish] RX_link

Metilfenobarbital [Inn-Spanish] fda sheet

Metilfenobarbital [Inn-Spanish] msds (material safety sheet)

Metilfenobarbital [Inn-Spanish] Synthesis Reference

No information avaliable

Metilfenobarbital [Inn-Spanish] Molecular Weight

246.262 g/mol

Metilfenobarbital [Inn-Spanish] Melting Point

176 oC

Metilfenobarbital [Inn-Spanish] H2O Solubility

Slightly soluble

Metilfenobarbital [Inn-Spanish] State


Metilfenobarbital [Inn-Spanish] LogP


Metilfenobarbital [Inn-Spanish] Dosage Forms


Metilfenobarbital [Inn-Spanish] Indication

For the relief of anxiety, tension, and apprehension, also used as an anticonvulsant for the treatment of epilepsy.

Metilfenobarbital [Inn-Spanish] Pharmacology

R-mephobarbital, a barbiturate, is used in combination with acetaminophen or aspirin and caffeine for its sedative and relaxant effects in the treatment of tension headaches, migraines, and pain. Barbiturates act as nonselective depressants of the central nervous system (CNS), capable of producing all levels of CNS mood alteration from excitation to mild sedation, hypnosis, and deep coma. In sufficiently high therapeutic doses, barbiturates induce anesthesia.

Metilfenobarbital [Inn-Spanish] Absorption

Approximately 50% of an oral dose of mephobarbital is absorbed from the gastrointestinal tract.

Metilfenobarbital [Inn-Spanish] side effects and Toxicity

No information avaliable

Metilfenobarbital [Inn-Spanish] Patient Information

No information avaliable

Metilfenobarbital [Inn-Spanish] Organisms Affected

Humans and other mammals